Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 148 articles: HTML format

Single Articles

July 2025
1. WU HL, Yang R, Liang XL, Ma R, et al
   Clinical Significance of Tumor-Infiltrating Lymphocytes in Malignant Peritoneal Mesothelioma: A Single-Center Study of 143 Cases.
   Ann Surg Oncol. 2025;32:5051-5062.
   PubMed     Abstract available
   
   
   
2. TANG WF, Qiu ZB, Chu XP, Zeng YM, et al
   EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities.
   Ann Surg Oncol. 2025;32:4641-4649.
   PubMed     Abstract available
   
   
   June 2025
3. KHAN AA, Shah SK, Basu S, Alex GC, et al
   ASO Visual Abstract: Thoracic Adipose Volume is Associated with Occult Nodal Disease- and Disease-Free Survival in Females with Clinically Node Negative Non-Small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Jun 14. doi: 10.1245/s10434-025-17634.
   PubMed    
   
   
   
4. LI Z, Wu J, Chen C, Liu C, et al
   ASO Visual Abstract: Longitudinal Trajectory of Patient-Reported Fatigue in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
   Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17574.
   PubMed    
   
   
   
5. KHAN AA, Shah SK, Basu S, Alex GC, et al
   Thoracic Adipose Volume is Associated with Occult Nodal Disease and Disease-Free Survival in Females with Clinically Node-Negative Non-Small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17485.
   PubMed     Abstract available
   
   
   
6. HASHINOKUCHI A, Kinoshita F, Iimori M, Kosai K, et al
   DNA Polymerase Delta 2 Activates Cell Cycle in Lung Adenocarcinoma, Leading to High Malignancy and Poor Prognosis.
   Ann Surg Oncol. 2025;32:4487-4496.
   PubMed     Abstract available
   
   
   
7. SINGH A, Xie Y, Mazzola E, Wang S, et al
   Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.
   Ann Surg Oncol. 2025;32:4181-4188.
   PubMed     Abstract available
   
   
   May 2025
8. NAEEM W, Khan AA, Adebayo OW, Ansari M, et al
   ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17521.
   PubMed    
   
   
   
9. NAEEM W, Khan AA, Seder CW
   ASO Author Reflections: Controversies at the Tumor Board-The Gray Areas in the Multimodality Treatment of Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 May 19. doi: 10.1245/s10434-025-17459.
   PubMed    
   
   
   
10. LI Z, Wu J, Chen C, Liu C, et al
    Longitudinal Trajectory of Patient-Reported Fatigue in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
    Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17444.
    PubMed     Abstract available
    
    
    
11. SU XE, Lin CL, Wang HG, Jing-Liu, et al
    Development and Validation of a Machine Learning-Based Predictive Model for Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its Relation to Early Recovery.
    Ann Surg Oncol. 2025 May 14. doi: 10.1245/s10434-025-17353.
    PubMed     Abstract available
    
    
    April 2025
12. NAEEM W, Khan AA, Adebayo OW, Ansari M, et al
    Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Apr 28. doi: 10.1245/s10434-025-17345.
    PubMed     Abstract available
    
    
    
13. UEDA D, Mimae T, Kamigaichi A, Tsubokawa N, et al
    Prognostic Benefit of Segmentectomy for Patients with Low Muscle Mass in Early-Stage Lung Cancer.
    Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-024-16384.
    PubMed     Abstract available
    
    
    
14. ASAMURA H, Yotsukura M, Rami-Porta R, Rusch VW, et al
    Updates on the Version 9 American Joint Committee on Cancer Staging System for Lung Cancer.
    Ann Surg Oncol. 2025 Apr 15. doi: 10.1245/s10434-025-17327.
    PubMed    
    
    
    
15. MATSUDO K, Takada K, Hashinokuchi A, Nagano T, et al
    Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common Mutations.
    Ann Surg Oncol. 2025;32:3031-3039.
    PubMed     Abstract available
    
    
    
16. LIANG XL, Su YD, Li XB, Fu YB, et al
    Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.
    Ann Surg Oncol. 2025;32:2912-2922.
    PubMed     Abstract available
    
    
    
17. CHEN PH, Chen C, Lu CW, Lu TP, et al
    Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma.
    Ann Surg Oncol. 2025;32:2675-2686.
    PubMed     Abstract available
    
    
    March 2025
18. JENKINS JA, Aly MR, Farina JM, Khedr A, et al
    ASO Visual Abstract: Money Matters-The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 30. doi: 10.1245/s10434-025-17240.
    PubMed    
    
    
    
19. BANKS KC, Sarovar V, Sun A, Wile RK, et al
    ASO Visual Abstract: The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 26. doi: 10.1245/s10434-025-17213.
    PubMed    
    
    
    
20. LAMPA E, Boros M, Berglund A, Wagenius G, et al
    Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer: A Target Trial Emulation Using Nationwide Swedish Registry Data.
    Ann Surg Oncol. 2025 Mar 19. doi: 10.1245/s10434-025-17193.
    PubMed     Abstract available
    
    
    
21. JENKINS JA, Aly MR, Farina JM, Khedr A, et al
    Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 12. doi: 10.1245/s10434-025-17107.
    PubMed     Abstract available
    
    
    
22. MADEKA I, Mack SJ, Rshaidat H, Ishwar A, et al
    Medicaid Expansion is Associated with Differences in Local Therapy for Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Mar 5. doi: 10.1245/s10434-025-17082.
    PubMed     Abstract available
    
    
    
23. WATERS J, Molena D
    Recent Noteworthy Studies in Thoracic Oncology.
    Ann Surg Oncol. 2025;32:1610-1616.
    PubMed     Abstract available
    
    
    
24. BASKIN AS, Burapachaisri K, Guha S, Velotta JB, et al
    The Landmark Series: Advances in Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer (NSCLC).
    Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-17008.
    PubMed     Abstract available
    
    
    February 2025
25. BANKS KC, Sarovar V, Sun A, Wile RK, et al
    The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Feb 20. doi: 10.1245/s10434-025-17034.
    PubMed     Abstract available
    
    
    
26. BASKIN AS, Velotta JB
    ASO Author Reflections: Preoperative Mediastinal Lymph Node Staging for Non-small Cell Lung Cancer: Where Do We Go from Here?
    Ann Surg Oncol. 2025 Feb 17. doi: 10.1245/s10434-025-17035.
    PubMed    
    
    
    
27. HUANG Y, Zeng H, Zhang G, Ren F, et al
    Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Populatio
    Ann Surg Oncol. 2025;32:760-770.
    PubMed     Abstract available
    
    
    
28. KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al
    Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
    Ann Surg Oncol. 2025;32:650-652.
    PubMed     Abstract available
    
    
    January 2025
29. MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al
    ASO Visual Abstract: Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Sarcoma Patients.
    Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16900.
    PubMed    
    
    
    
30. AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al
    ASO Visual Abstract: Is Sublobar Resection Feasible for High-Risk Pathological Stage I Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2025 Jan 27. doi: 10.1245/s10434-025-16907.
    PubMed    
    
    
    
31. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
    Re: The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer Re: Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The Interdisciplinary Approach to
    Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16865.
    PubMed    
    
    
    
32. MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al
    Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Patients with Sarcoma.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16800.
    PubMed     Abstract available
    
    
    
33. LI Z, He Z, Xu W, Pan X, et al
    The Necessity of Lymphadenectomy for Non-Small Cell Lung Cancer Smaller Than 6 mm in Solid Size.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16675.
    PubMed     Abstract available
    
    
    December 2024
34. ZHANG B, Xia L, Zhu X, Zhang L, et al
    Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The Interdisciplinary Approach to Postoperative Management.
    Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16733.
    PubMed     Abstract available
    
    
    
35. AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al
    Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2024 Dec 16. doi: 10.1245/s10434-024-16700.
    PubMed     Abstract available
    
    
    
36. PACHIMATLA AG, Gee K, Hsiao HH, Yendamuri S, et al
    Image-Based Measures of Obesity are Associated with Alterations in Metabolic Pathways in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Dec 13. doi: 10.1245/s10434-024-16402.
    PubMed     Abstract available
    
    
    
37. LIU J, Cao B, Shi Z, Liu X, et al
    Correlation Between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:9310-9320.
    PubMed     Abstract available
    
    
    
38. XIANG Y, Zhou K, Fang C, Han W, et al
    Impact of Tumor Size and Differentiation Grade on Survival After Lobectomy and Segmentectomy for Patients with Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:9289-9297.
    PubMed     Abstract available
    
    
    November 2024
39. WEI X, Liu J, Cao B, Shi Q, et al
    Image-Based Assessment of Obesity and Metabolic Pathway Alterations in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16617.
    PubMed    
    
    
    
40. LIU W, Yue D, Zhang B
    ASO Author Reflections: The Candidate Biomarkers for Predicting Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16150.
    PubMed    
    
    
    
41. UEDA D, Mimae T, Okada M
    ASO Author Reflections: Surgical Procedures for Early-Stage Lung Cancer Patients with Low Muscle Mass.
    Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16481.
    PubMed    
    
    
    
42. GONG S, Li G, Wu B
    Prognostic Role of Emphysema in Surgical Stage I Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16427.
    PubMed    
    
    
    
43. KAR M
    The Impact of Sarcopenia on Outcomes in Video-Assisted Thoracoscopic Surgery (VATS) for Lung Cancer.
    Ann Surg Oncol. 2024 Nov 7. doi: 10.1245/s10434-024-16447.
    PubMed    
    
    
    
44. HONG Q, Chen H, Yi H, Mu J, et al
    Virtual Reality: Pioneering the Future of Precision in Anatomical Partial Lobectomy.
    Ann Surg Oncol. 2024;31:7665-7667.
    PubMed    
    
    
    
45. WU J, Li C, Liu C
    Uniportal Thoracoscopic Complex Combined Seg-Sub-subsegmentectomy of RS9+10bii: Dual-Display Method and Combined Approaches (Trans-fissure and Trans-ligament).
    Ann Surg Oncol. 2024;31:7775-7776.
    PubMed     Abstract available
    
    
    
46. NAKAMURA A, Hashimoto M, Kuroda A, Takegahara K, et al
    Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma.
    Ann Surg Oncol. 2024;31:7767-7774.
    PubMed     Abstract available
    
    
    October 2024
47. KAO TN, Chiang XH, Kuo SW, Huang PM, et al
    ASO Visual Abstract: Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Oct 31. doi: 10.1245/s10434-024-16394.
    PubMed    
    
    
    
48. KAO TN, Chiang XH, Kuo SW, Huang PM, et al
    Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Oct 24. doi: 10.1245/s10434-024-16338.
    PubMed     Abstract available
    
    
    
49. NAKAMURA A, Hashimoto M, Funaki S, Hasegawa S, et al
    ASO Author Reflections: Postoperative Peritoneal Dissemination Recurrence of Pleural Mesothelioma has a Poor Prognosis.
    Ann Surg Oncol. 2024;31:6729-6730.
    PubMed    
    
    
    
50. LIU J, Cao B, Shi Z, Liu X, et al
    ASO Author Reflections: Correlation between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:6727-6728.
    PubMed    
    
    
    
51. WU J, Liu C
    ASO Author Reflections: Uniportal Thoracoscopic Highly Complex Basal Segmentectomies-Demanding Techniques are Needed.
    Ann Surg Oncol. 2024;31:6720-6721.
    PubMed    
    
    
    
52. NAGANO T, Takada K, Takenaka T, Yoshizumi T, et al
    ASO Author Reflections: Relationship Between SIRPalpha Expression on Tumor-Associated Macrophages and Tumor Microenvironment in Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2024;31:6725-6726.
    PubMed    
    
    
    
53. ROCCO G
    Predicting Lung Function After Segmentectomy.
    Ann Surg Oncol. 2024;31:6359-6360.
    PubMed    
    
    
    
54. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in Patients Undergoing Segmentectomy: A Retrospective Study.
    Ann Surg Oncol. 2024;31:6645-6651.
    PubMed     Abstract available
    
    
    September 2024
55. BRUNELLI A
    Wedge or Segmentectomy for Early-Stage Non-Small Cell Lung Cancer? The Dilemma Remains Unresolved.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16257.
    PubMed    
    
    
    
56. LAI Y, Dong Y, Che GW
    ASO Author Reflections: Prerehabilitation with High-Intensive Model for Surgical Lung Cancer Patients.
    Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16151.
    PubMed    
    
    
    
57. LAI Y, Dong Y, Tian L, Li H, et al
    The Optimal Time of High-Intensity Pre-rehabilitation for Surgical Lung Cancer Patients: A Retrospective Cohort Study with 4452 Patients.
    Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16054.
    PubMed     Abstract available
    
    
    
58. BOUTROS CS, Arora RC, Towe CW
    Optimizing Preoperative Rehabilitation: Shaping the Future of Lung Cancer Surgery Outcomes.
    Ann Surg Oncol. 2024 Sep 17. doi: 10.1245/s10434-024-16256.
    PubMed    
    
    
    
59. LIU J, Qing H
    ASO Author Reflections: Impact of Sarcopenia on Patient-Reported Outcomes After Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16241.
    PubMed    
    
    
    
60. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    ASO Visual Abstract: Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in Patients Undergoing Segmentectomy-A Retrospective Study.
    Ann Surg Oncol. 2024;31:5783-5784.
    PubMed    
    
    
    
61. NAGANO T, Takada K, Narutomi F, Kinoshita F, et al
    Clinical Significance of SIRPalpha Expression on Tumor-Associated Macrophages in Patients with Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2024;31:6309-6319.
    PubMed     Abstract available
    
    
    
62. YASAR S
    ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.
    Ann Surg Oncol. 2024;31:6276-6277.
    PubMed    
    
    
    
63. OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al
    What is the Optimal Resection Extent for Preserving Respiratory Function in Segmentectomy?: Insights on Lung Resection Volume and Respiratory Function.
    Ann Surg Oncol. 2024;31:5766-5767.
    PubMed    
    
    
    
64. VAN HAREN RM, Kovacic MB, Delman AM, Pratt CG, et al
    Disparities Associated with Decision to Undergo Oncologic Surgery: A Prospective Mixed-Methods Analysis.
    Ann Surg Oncol. 2024;31:5757-5764.
    PubMed     Abstract available
    
    
    
65. JIA J, Zhang G, Wei L, Qi L, et al
    The Battle for Accuracy: Identifying the Most Effective Grading System for Lung Invasive Mucinous Adenocarcinoma.
    Ann Surg Oncol. 2024;31:5717-5728.
    PubMed     Abstract available
    
    
    
66. FUJIWARA W, Yotsukura M, Yoshida Y, Nakagawa K, et al
    Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.
    Ann Surg Oncol. 2024;31:5697-5705.
    PubMed     Abstract available
    
    
    
67. YASAR S, Yilmaz F, Utkan G, Algin E, et al
    Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.
    Ann Surg Oncol. 2024;31:6228-6236.
    PubMed     Abstract available
    
    
    
68. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
    ASO Author Reflections: Is the VATS Technique Superior to Thoracotomy Techniques in Terms of Respiratory Muscle Function and Functional Exercise Capacity?
    Ann Surg Oncol. 2024;31:5768-5769.
    PubMed    
    
    
    August 2024
69. LIU J, Li D, Ma H, Li Y, et al
    Early Postoperative Patient-Reported Outcomes of Sarcopenia Versus Nonsarcopenia in Patients Undergoing Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2024 Aug 31. doi: 10.1245/s10434-024-16140.
    PubMed     Abstract available
    
    
    
70. MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al
    ASO Author Reflections: Utility of Sublobar Resection for Small-Sized Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-16126.
    PubMed    
    
    
    
71. LIU W, Chen C, Li C, Wu X, et al
    Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16053.
    PubMed     Abstract available
    
    
    
72. MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al
    Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-16027.
    PubMed     Abstract available
    
    
    
73. TANE S
    The Crucial Value of Glutathione Peroxidase 2 to Understand the 'Two-Faced' Role of Reactive Oxygen Species in Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:4849-4850.
    PubMed    
    
    
    
74. HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al
    ASO Visual Abstract: Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:5098.
    PubMed    
    
    
    
75. WOO W, Park CH, Lee J, Moon DH, et al
    Left Upper Division Segmentectomy Compared with Lobectomy for Lung Expansion and Bronchus Tortuosity.
    Ann Surg Oncol. 2024;31:5021-5027.
    PubMed     Abstract available
    
    
    
76. HASHINOKUCHI A, Matsubara T, Takenaka T, Yoshizumi T, et al
    ASO Author Reflections: Impact of Glutathione Peroxidase 2 (GPX2) in Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:5092-5093.
    PubMed    
    
    
    July 2024
77. MCGANN K, Demarest CT
    Lobectomy Versus Segmentectomy for Early-Stage Non-small Cell Lung Cancer: Is Less More?
    Ann Surg Oncol. 2024 Jul 30. doi: 10.1245/s10434-024-15883.
    PubMed    
    
    
    
78. WEI W, Wang Y, Ouyang R, Wang T, et al
    Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data.
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15762.
    PubMed     Abstract available
    
    
    
79. SHAH SK, Krishnan V, Khan AA, Fass L, et al
    Women are Underrepresented in Non-small Cell Lung Cancer Clinical Trials: A Systematic Review.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15720.
    PubMed     Abstract available
    
    
    
80. SHAH SK, Khan AA, Alex GC
    ASO Author Reflections: Getting a Seat at the Table-A Call for Equitable Inclusion of Women in Lung Cancer Clinical Trials.
    Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15778.
    PubMed    
    
    
    
81. CHEUN JH, Chung S, Han JH, Lee YW, et al
    Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
    PubMed     Abstract available
    
    
    
82. RANDLE RJ, Bhandari P, He H, Berry MF, et al
    Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After Pulmonary Surgery.
    Ann Surg Oncol. 2024;31:4308-4316.
    PubMed     Abstract available
    
    
    
83. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
    Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Ann Surg Oncol. 2024;31:4339-4348.
    PubMed     Abstract available
    
    
    
84. HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al
    Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:4822-4829.
    PubMed     Abstract available
    
    
    June 2024
85. LI X, Fan F, Chen H
    ASO Author Reflections: Long-Term Follow-Up Results of Stage IA Invasive Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15615.
    PubMed    
    
    
    
86. KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al
    ASO Visual Abstract: Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer After Complete Resection.
    Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15628.
    PubMed    
    
    
    
87. LI X, Fan F, Yang Z, Huang Q, et al
    Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Jun 18. doi: 10.1245/s10434-024-15572.
    PubMed     Abstract available
    
    
    
88. BANSAL VV, Mitchell O, Drazer MW, Kindler HL, et al
    ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma.
    Ann Surg Oncol. 2024;31:3785-3786.
    PubMed    
    
    
    
89. KOTI S, Demyan L, Deutsch G, Weiss M, et al
    Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
    Ann Surg Oncol. 2024;31:4031-4041.
    PubMed     Abstract available
    
    
    
90. SHARMA J, Deo SVS, Kumar S, Bhoriwal S, et al
    Malignant Chest Wall Tumors: Complex Defects and Their Management-A Review of 181 Cases.
    Ann Surg Oncol. 2024;31:3675-3683.
    PubMed     Abstract available
    
    
    May 2024
91. AL-KASSPOOLES M, Wilkerson J
    Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15406.
    PubMed    
    
    
    
92. ISHIDA M, Mimae T, Kamigaichi A, Kawamoto N, et al
    The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer.
    Ann Surg Oncol. 2024 May 13. doi: 10.1245/s10434-024-15126.
    PubMed     Abstract available
    
    
    
93. DENG HY, Zhou Q
    Pleural Invasion in Non-small Cell Lung Cancer: An Important Characteristic during Clinical Decision-Making.
    Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15401.
    PubMed    
    
    
    
94. ISHIDA M, Mimae T, Okada M
    ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After Lung Cancer Surgery?
    Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15171.
    PubMed    
    
    
    
95. APRILE V, Ambrogi MC, Lucchi M
    Surgery in Stage IV Non-small Cell Lung Cancer: Good Time for a Chance.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15308.
    PubMed    
    
    
    
96. YAN HJ, Zhao JS, Liu Q, Yang C, et al
    ASO Author Reflections: The Clinical Use of Dual-Region Radiomics-Based Machine Learning in the Identification of Subcarinal Lymph Node Metastasis of Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15271.
    PubMed    
    
    
    
97. BANSAL VV, Mitchell O, Bregio C, Witmer HDD, et al
    Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk.
    Ann Surg Oncol. 2024;31:3339-3349.
    PubMed     Abstract available
    
    
    
98. GRAUR A, Saenger JA, Mercaldo ND, Simon J, et al
    Multimodality Management of Thoracic Tumors: Initial Experience With a Multidisciplinary Thoracic Ablation Conference.
    Ann Surg Oncol. 2024;31:3426-3436.
    PubMed     Abstract available
    
    
    April 2024
99. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
    The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer.
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15312.
    PubMed     Abstract available
    
    
    
100. KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al
     Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.
     Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15279.
     PubMed     Abstract available
     
     
     
101. LIU J, Shi Z, Cao B, Wang Z, et al
     ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients.
     Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243.
     PubMed    
     
     
     
102. SARVESTANI AL, Lambdin J, Hu M, Cabanillas M, et al
     Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.
     Ann Surg Oncol. 2024;31:2202-2203.
     PubMed    
     
     
     
103. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
     ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.
     Ann Surg Oncol. 2024;31:2511-2512.
     PubMed    
     
     
     
104. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
     ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
     Ann Surg Oncol. 2024;31:2521-2522.
     PubMed    
     
     
     March 2024
105. YAN HJ, Zhao JS, Zuo HD, Zhang JJ, et al
     Dual-Region Computed Tomography Radiomics-Based Machine Learning Predicts Subcarinal Lymph Node Metastasis in Patients with Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15197.
     PubMed     Abstract available
     
     
     
106. LIU J, Shi Z, Cao B, Wang Z, et al
     Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15184.
     PubMed     Abstract available
     
     
     
107. GRENDA TR
     Refocusing the Prognosis Lens: Conditional Survival After Surgery in Limited-Stage Small Cell Lung Cancer.
     Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168.
     PubMed    
     
     
     
108. PARK S, Choe J, Lee SM, Choi S, et al
     ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
     Ann Surg Oncol. 2024 Mar 14. doi: 10.1245/s10434-024-15135.
     PubMed    
     
     
     
109. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
     ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:1597-1598.
     PubMed    
     
     
     
110. YOON DW, Hwang S, Hong TH, Choi YL, et al
     ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
     Ann Surg Oncol. 2024;31:1591-1592.
     PubMed    
     
     
     
111. PAN H, Huang J, Luo Q
     ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for Sublobar Resection in Octogenarians with Pulmonary Nodules
     Ann Surg Oncol. 2024;31:1585-1586.
     PubMed    
     
     
     
112. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
     CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
     Ann Surg Oncol. 2024;31:1536-1545.
     PubMed     Abstract available
     
     
     February 2024
113. LIN JP, Liu SY, Wang F
     ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
     Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062.
     PubMed    
     
     
     
114. PARK S, Choe J, Lee SM, Choi S, et al
     Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
     Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984.
     PubMed     Abstract available
     
     
     
115. LIN JP, Chen XF, Wang P, He H, et al
     Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study.
     Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983.
     PubMed     Abstract available
     
     
     
116. XU SJ, Chen C, Tu JH, You CX, et al
     ASO Visual Abstract: Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma-A Multicenter, Retrospective Study.
     Ann Surg Oncol. 2024;31:906-907.
     PubMed    
     
     
     
117. XU SJ, Chen C, Tu JH, You CX, et al
     Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
     Ann Surg Oncol. 2024;31:872-882.
     PubMed     Abstract available
     
     
     January 2024
118. KAZZI B, Mankuzhy NP, Swami N, Jain B, et al
     Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups.
     Ann Surg Oncol. 2024 Jan 28. doi: 10.1245/s10434-024-14952.
     PubMed    
     
     
     
119. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
     ASO Visual Abstract: Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer-A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
     Ann Surg Oncol. 2024 Jan 24. doi: 10.1245/s10434-024-14928.
     PubMed    
     
     
     
120. CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
     Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
     Ann Surg Oncol. 2024;31:556-566.
     PubMed     Abstract available
     
     
     
121. LI W, Yang Y, Yang M, Song N, et al
     Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.
     Ann Surg Oncol. 2024;31:167-177.
     PubMed     Abstract available
     
     
     
122. WOODARD GA, Cho C, Chen L
     Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
     Ann Surg Oncol. 2024;31:25-27.
     PubMed    
     
     
     
123. YANG X, Xiao Y, Hu H, Qiu ZB, et al
     ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules-A Large Study of 2022 Cases in China.
     Ann Surg Oncol. 2024;31:245-246.
     PubMed    
     
     
     
124. YOON DW, Hwang S, Hong TH, Choi YL, et al
     Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
     Ann Surg Oncol. 2024;31:201-212.
     PubMed     Abstract available
     
     
     December 2023
125. MI J, Li C, Yang F, Shi X, et al
     ASO Visual Abstract: Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
     Ann Surg Oncol. 2023 Dec 26. doi: 10.1245/s10434-023-14795.
     PubMed    
     
     
     
126. PAN H, Zou N, Tian Y, Shen Y, et al
     ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
     Ann Surg Oncol. 2023 Dec 22. doi: 10.1245/s10434-023-14799.
     PubMed    
     
     
     
127. OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al
     Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
     Ann Surg Oncol. 2023 Dec 21. doi: 10.1245/s10434-023-14798.
     PubMed     Abstract available
     
     
     
128. DIAO H, Xu L, Li X, Wang Y, et al
     Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2023 Dec 17. doi: 10.1245/s10434-023-14767.
     PubMed     Abstract available
     
     
     
129. PAN H, Zou N, Tian Y, Shen Y, et al
     Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
     Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14689.
     PubMed     Abstract available
     
     
     
130. MI J, Li C, Yang F, Shi X, et al
     Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows.
     Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14677.
     PubMed     Abstract available
     
     
     
131. KINOSHITA F, Takada K, Wakasu S, Saito S, et al
     ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins.
     Ann Surg Oncol. 2023;30:8290-8291.
     PubMed    
     
     
     November 2023
132. MACHADO PFA, Oliveiros B, Martins RA, Cruz J, et al
     ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on Quality of Life After Lung Cancer Resection.
     Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620.
     PubMed    
     
     
     
133. MACHADO PFA, Pimenta S, Garcia AL, Nogueira T, et al
     ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
     Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602.
     PubMed    
     
     
     
134. MACHADO P, Pimenta S, Garcia AL, Nogueira T, et al
     Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
     Ann Surg Oncol. 2023 Nov 7. doi: 10.1245/s10434-023-14503.
     PubMed     Abstract available
     
     
     
135. YANG X, Xiao Y, Hu H, Qiu ZB, et al
     Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
     Ann Surg Oncol. 2023;30:7400-7411.
     PubMed     Abstract available
     
     
     
136. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
     ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model.
     Ann Surg Oncol. 2023;30:7858-7859.
     PubMed    
     
     
     
137. VILLENA-VARGAS J
     Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape.
     Ann Surg Oncol. 2023;30:6972-6973.
     PubMed    
     
     
     
138. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
     2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
     Ann Surg Oncol. 2023;30:7803-7813.
     PubMed     Abstract available
     
     
     
139. KOSAI K, Masuda T, Kitagawa A, Tobo T, et al
     Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
     Ann Surg Oncol. 2023;30:7538-7548.
     PubMed     Abstract available
     
     
     
140. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
     Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
     Ann Surg Oncol. 2023;30:7527-7537.
     PubMed     Abstract available
     
     
     October 2023
141. RUCK JM, Broderick SR
     Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab.
     Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14356.
     PubMed    
     
     
     
142. SWANSON SJ
     Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System-All "Segmentectomies" Are Not Created Equal.
     Ann Surg Oncol. 2023;30:6315.
     PubMed    
     
     
     
143. YAO F, Wu W, Zhu Q, Zhu Y, et al
     ASO Visual Abstract: Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
     Ann Surg Oncol. 2023;30:6717.
     PubMed    
     
     
     
144. ALEXANDER HR
     Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don't Put the Cart Before the Horse.
     Ann Surg Oncol. 2023;30:6301-6303.
     PubMed    
     
     
     
145. YAO F, Wu W, Zhu Q, Zhu Y, et al
     Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
     Ann Surg Oncol. 2023;30:6707-6716.
     PubMed     Abstract available
     
     
     September 2023
146. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
     ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14311.
     PubMed    
     
     
     
147. FU F, Zhang Y, Chen H
     ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14265.
     PubMed    
     
     
     
148. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
     Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
     Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14176.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.